Clinical Trial Update: Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing radiochemotherapy with the Folfox-4 regimen to 5-FU plus cisplatin in patients with inoperable esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)

Snippet

Sponsor: Sanofi | Conditions: Esophageal Neoplasms | Phase 2 | Status: COMPLETED